ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Dingxin recipe III ameliorates hyperlipidemia injury in SD rats by improving the gut barrier, particularly the SCFAs/GPR43 pathway

Gu, Yu-yan; Cui, Xiao-bing; Jiang, Jing; Zhang, Ya-xin; Liu, Meng-hua; Cheng, Sai-bo; Li, Yu-ye; Liu, Lin -ling; Liao, Rong-xin; Zhao, Peng; Jin, Wen; Jia, Yu-hua*; Wang, Jing*; Zhou, Feng-hua*广州中医药大学; 南方医科大学; 1
Journal of Ethnopharmacology2023-8-10DOI: 10.1016/j.jep.2023.116483
11阅读
引用收藏
分享

摘要

Ethnopharmacological relevance: Dingxin Recipe III (DXR III) is a traditional Chinese medicine compound used for hyperlipidemia treatment in clinical practice. However, its curative effects and pharmacological mechanisms in hyperlipidemia have not been clarified to date. Aim of the study: Studies have demonstrated that gut barrier was strongly implicated in lipid deposition. Based on gut barrier and lipid metabolism, this study examined the effects and molecular mechanisms of DXR III in hyperlipidemia. Materials and methods: The bioactive compounds of DXR III were detected by ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry, and its effects were evaluated in high-fat diet-fed rats. Specifically, the serum levels of lipids and hepatic enzymes were measured using the appropriate kits; colon and liver sections were obtained for histological analyses; gut microbiota and metabolites were analyzed by 16S rDNA sequencing and liquid chromatography-MS/MS; and the expression of genes and proteins was determined by real-time quantitative polymerase chain reaction and western blotting and immunohistochemistry, respec-tively. The pharmacological mechanisms of DXR III were further explored by fecal microbiota transplantation and short-chain fatty acid (SCFAs)-based interventions. Results: DXR III treatment significantly downregulated serum lipid levels, mitigated hepatocyte steatosis and improved lipid metabolism. Moreover, DXR III improved the gut barrier, specifically by improving the physical barrier in the colon, causing part composition changes in the gut microbiota, and increasing the serum SCFAs level. DXR III also upregulated the expression of colon GPR43/GPR109A. Fecal microbiota transplantation from rats treated with DXR III downregulated part hyperlipidemia-related phenotypes, while the SCFAs intervention significantly improved most of the hyperlipidemia-related phenotypes and upregulated the expression of GPR43. Moreover, both DXR III and SCFAs upregulated the expression of colon ABCA1.Conclusion: DXR III protects against hyperlipidemia by improving the gut barrier, particularly the SCFAs/GPR43 pathway.

学科与关键词

关键词
HyperlipidemiaGut microbiotaSCFAsLipid metabolismDXR III
相关
加载中…
  • Dingxin Recipe IV attenuates atherosclerosis by regulating lipid metabolism through LXR-α/SREBP1 pathway and modulating the gut microbiota in ApoE-/- mice fed with HFD
    Zhang, Yaxin; Gu, Yuyan; Chen, Yihao; Huang, Zhiyong; Li, Mei; Jiang, Weihao; Chen, Jiahui; Rao, Wenting; Luo, Shangfei; Chen, Yuyao; Chen, Junqi; Li, Lijun; Jia, Yuhua*; Liu, Menghua*; Zhou, Fenghua*Journal of Ethnopharmacology, 2021, 266: 113436.被引 48
  • Metabolomic and Microbial Remodeling by Shanmei Capsule Improves Hyperlipidemia in High Fat Food-Induced Mice
    Du, Lijing; Wang, Qian; Ji, Shuai; Sun, Yuanfang; Huang, Wenjing; Zhang, Yiping; Li, Shasha; Yan, Shikai*; Jin, Huizi*Frontiers in Cellular and Infection Microbiology, 2022, 12: 729940.被引 7
  • Effect of Bergamot and Laoxianghuang Polysaccharides on Gut Microbiota Derived from Patients with Hyperlipidemia: An Integrative Analysis of Microbiome and Metabolome during In Vitro Fermentation
    Zheng, Yang; Wang, Yi; Luo, Donghui; Lin, Lianzhu; Lu, Xingyu; Gao, Jie; Xiao, Chuqiao*; Zhao, Mouming*Foods, 2022, 11(14): 2039.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Ethnopharmacology
发表日期
2023-08-10
卷期
第 312 卷
页码
116483
DOI
10.1016/j.jep.2023.116483
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [0.82174299, 81973802, 82074424]; Traditional Chinese Medicine Bureau of Guangdong Prov- ince, China [20222137, 20231184]; Guangzhou Municipal Science and Technology Project, China [202201011647]; Guangdong Provincial Natural Science Foundation, China [2023A1515010451]

作者

  • G

    Gu, Yu-yan (第一作者)

    southern med univ

  • C

    Cui, Xiao-bing

    southern med univ · 1 · guangzhou univ chinese med

查看全部 14 位作者收起作者
  • J

    Jiang, Jing

    southern med univ

  • Z

    Zhang, Ya-xin

    southern med univ

  • L

    Liu, Meng-hua

    southern med univ

  • C

    Cheng, Sai-bo

    southern med univ

  • L

    Li, Yu-ye

    southern med univ

  • L

    Liu, Lin -ling

    southern med univ

  • L

    Liao, Rong-xin

    southern med univ

  • Z

    Zhao, Peng

    southern med univ

  • J

    Jin, Wen

    2

  • J

    Jia, Yu-hua (通讯)

    southern med univ

  • W

    Wang, Jing (通讯)

    southern med univ

  • Z

    Zhou, Feng-hua (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417